ChemDiv Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:ChemDiv Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014389
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ChemDiv Inc (ChemDiv), a subsidiary of ChemRar High-Tech Center is a contract research organization that offers chemistry services, hit finding, integrated drug discovery, pharmatech services, disease based models, drug development, and others. The organization also offers chemistry building blocks and screening libraries. It offers customized services for research and development chemistry, biology and to meet various clinical needs of its customers. ChemDiv partners with various large and small pharma and biotech, academia, foundations and screening centers. The organization operates various research and development centers in Russia, Ukraine, and China. ChemDiv is headquartered in San Diego, California, the US.

ChemDiv Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ChemDiv Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ChemDiv Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ChemDiv Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ChemDiv Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
ChemDiv Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
ChemDiv Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
ChemDiv Enters into Co-Development Agreement with Context Therapeutics and Torrey Pines Investment 10
Regen BioPharma Enters into Agreement with ChemDiv 11
Janssen Research & Development Enters into Agreement with ChemDiv 12
ChemDiv, Torrey Pines Investment and DZNE Enter into Research Agreement 13
ChemDiv Enters into Agreement with Cystic Fibrosis Foundation Therapeutics 14
Coare Biotech Enters Into Agreement With ChemDiv To Offer Gene-To-Clinic Services 15
ChemDiv Enters Into Research Agreement With Janssen Pharmaceutica And Tibotec Pharma 16
Emerald BioStructures Enters Into Co-Marketing Agreement With ChemDiv 17
ChemDiv Inc – Key Competitors 18
ChemDiv Inc – Key Employees 19
ChemDiv Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Government and Public Interest 21
Aug 17, 2017: Australian researchers make a breakthrough in finding cure for peanut allergy 21
Aug 15, 2017: Potential broad-spectrum antiviral discovered in herpesvirus study 22
Product News 23
Apr 18, 2017: Regen BioPharma Identifies Three New Series of Compounds That Activate NR2F6 23
Mar 23, 2017: Regen BioPharma Provides Update on NR2F6 Small Molecule Optimization Program for Treating Cancer and Arthritis 24
Jan 11, 2016: ChemDiv Announces Achievement of a Development Milestone in a Drug Discovery Collaboration With Janssen 25
Other Significant Developments 26
Oct 09, 2017: China to accept overseas trial data in bid to speed up drug approvals 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
ChemDiv Inc, Pharmaceuticals & Healthcare, Key Facts 2
ChemDiv Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
ChemDiv Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
ChemDiv Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
ChemDiv Inc, Deals By Therapy Area, 2011 to YTD 2017 8
ChemDiv Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
ChemDiv Enters into Co-Development Agreement with Context Therapeutics and Torrey Pines Investment 10
Regen BioPharma Enters into Agreement with ChemDiv 11
Janssen Research & Development Enters into Agreement with ChemDiv 12
ChemDiv, Torrey Pines Investment and DZNE Enter into Research Agreement 13
ChemDiv Enters into Agreement with Cystic Fibrosis Foundation Therapeutics 14
Coare Biotech Enters Into Agreement With ChemDiv To Offer Gene-To-Clinic Services 15
ChemDiv Enters Into Research Agreement With Janssen Pharmaceutica And Tibotec Pharma 16
Emerald BioStructures Enters Into Co-Marketing Agreement With ChemDiv 17
ChemDiv Inc, Key Competitors 18
ChemDiv Inc, Key Employees 19

★海外企業調査レポート[ChemDiv Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grupo Aval Acciones Y Valores Sa:企業の戦略・SWOT・財務分析
    Grupo Aval Acciones Y Valores Sa - Strategy, SWOT and Corporate Finance Report Summary Grupo Aval Acciones Y Valores Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Dana Petroleum Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Dana Petroleum Ltd (Dana), a wholly-owned subsidiary of Korea National Oil Corp (KNOC), is an upstream oil and gas company. It explores, develops and produces oil and gas from its assets in the Europe and the Middle East. The company has interests and operations in the UK, the Netherlands, D …
  • Howmet Aerospace Inc (HWM):企業の財務・戦略的SWOT分析
    Howmet Aerospace Inc (HWM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Aixtron SE (AIXA):企業の財務・戦略的SWOT分析
    Aixtron SE (AIXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BBB Technologies Inc:企業の製品パイプライン分析2018
    Summary BBB Technologies Inc (BBB Tech) is a development stage medical technology company that develops medical devices and applications that facilitate the early diagnosis of metabolic and cardiovascular disorders. The company discovers and develops single-drop and mobile integrated diagnostic tool …
  • Emcure Pharmaceuticals Ltd:企業の戦略的SWOT分析
    Emcure Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • California Pizza Kitchen, Inc.
    California Pizza Kitchen, Inc. - Strategy, SWOT and Corporate Finance Report Summary California Pizza Kitchen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • China Development Bank:企業の戦略・SWOT・財務情報
    China Development Bank - Strategy, SWOT and Corporate Finance Report Summary China Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • AltaGas Ltd (ALA)-エネルギー分野:企業M&A・提携分析
    Summary AltaGas Ltd. (AltaGas), is an energy utility. The company undertakes activities related to extraction, transmission, distribution and storage of natural gas. AltaGas generates electricity utilizing diverse fuel sources, such as wind, run-of-river hydro, geothermal and gas-fired generation pl …
  • Rolls-Royce Holdings Plc:企業のM&A・事業提携・投資動向
    Rolls-Royce Holdings Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rolls-Royce Holdings Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • The Cooper Companies, Inc.:企業の戦略・SWOT・財務情報
    The Cooper Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Cooper Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • SunPower Corporation:企業の戦略・SWOT・財務情報
    SunPower Corporation - Strategy, SWOT and Corporate Finance Report Summary SunPower Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • UroGen Pharma Ltd (URGN)-製薬・医療分野:企業M&A・提携分析
    Summary UroGen Pharma Ltd (UroGen Pharma), formerly TheraCoat Ltd is a biopharmaceutical company that develops uro-oncology drugs and urological pathologies. The company’s pipeline products comprise drug candidates for various forms of non-muscle invasive urothelial cancer, including low grade bladd …
  • Zagro Asia Ltd:企業の戦略的SWOT分析
    Zagro Asia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Kalvista Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Kalvista Pharmaceuticals Ltd (Kalvista Pharma), formerly Kalvista Limited, is a pharmaceutical company which focuses on the discovery, development and commercialization of small molecule serine protease inhibitors. It develops a proprietary portfolio of small molecule plasma kallikrein inhib …
  • Aethlon Medical Inc (AEMD):医療機器:M&Aディール及び事業提携情報
    Summary Aethlon Medical Inc (Aethlon Medical) is a developer of therapeutic technologies that address unmet needs in biodefense and global health. It develops immunotherapeutic technologies for the treatment of cancer and infectious diseases. The company’s lead product, Hemopurifier, strengthens nat …
  • Tepha Inc-医療機器分野:企業M&A・提携分析
    Summary Tepha Inc (Tepha) is a medical device company that develops and commercializes medical device components and finished goods. The company offers products such as absorbable monofilament suture, absorbable monofilament mesh, composite mesh and absorbable surgical film. It also provides platfor …
  • Secure Trust Bank Plc:企業の戦略・SWOT・財務情報
    Secure Trust Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Secure Trust Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sidi Kerir Petrochemicals Co (SKPC):企業の財務・戦略的SWOT分析
    Summary Sidi Kerir Petrochemicals Co (Sidpec), a subsidiary of Egyptian Petrochemicals Holding Co, is a chemical company that manufactures and distributes petrochemical products. The company offers high density polyethylene and linear low density polyethylene which are used in plastic applications i …
  • SimCorp AS (SIM):企業の財務・戦略的SWOT分析
    SimCorp AS (SIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆